|
127 Companies |
|
139 Products |
|
139 Products |
|
89 Mechanisms of Action |
|
9 Trials |
|
1220 News |
|
| «12...910111213141516171819...2425» |
- |||| camicinal (GSK962040) / GSK
Enrollment open: Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study (clinicaltrials.gov) - Apr 23, 2014
P2, N=150, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting
- Trial completion: Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis (clinicaltrials.gov) - Apr 23, 2014
P=N/A, N=200, Completed, Sponsor: University of Iowa
Not yet recruiting --> Recruiting Recruiting --> Completed
- || New P3 trial: An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial (clinicaltrials.gov) - Apr 21, 2014
P3, N=70, Recruiting, Sponsor: Yonsei University
- | Enrollment open: An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial (clinicaltrials.gov) - Apr 21, 2014
P3, N=70, Recruiting, Sponsor: Yonsei University
Recruiting --> Completed Not yet recruiting --> Recruiting
- lansoprazole / Generic mfg.
Trial termination: Lansoprazole for Subgroups of Functional Dyspepsia (clinicaltrials.gov) - Apr 12, 2014
P4, N=30, Terminated, Sponsor: National Taiwan University Hospital
Not yet recruiting --> Recruiting Recruiting --> Terminated; failure to recruit enough patients
- lansoprazole / Generic mfg.
Enrollment change: Lansoprazole for Subgroups of Functional Dyspepsia (clinicaltrials.gov) - Apr 12, 2014
P4, N=30, Terminated, Sponsor: National Taiwan University Hospital
Recruiting --> Terminated; failure to recruit enough patients N=450 --> 30
- || New P3 trial, HEOR: WCGCC-1202: Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy (clinicaltrials.gov) - Apr 8, 2014
P3, N=588, Not yet recruiting, Sponsor: West China Hospital
- ||| Enrollment open: Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=250, Recruiting, Sponsor: Given Imaging Ltd.
N=450 --> 30 Not yet recruiting --> Recruiting
- Trial completion, MRI: Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive Imaging (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=72, Completed, Sponsor: Nottingham University Hospitals NHS Trust
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open: SAFE-T: Safety and Feasibility of TachoSil (clinicaltrials.gov) - Apr 3, 2014
P=N/A, N=15, Recruiting, Sponsor: R. van Hillegersberg
Recruiting --> Completed Not yet recruiting --> Recruiting
- veliparib (ABT-888) / AbbVie
Enrollment change, Combination therapy, BRCA Biomarker, PARP Biomarker, Metastases: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Mar 31, 2014
P1, N=16, Terminated, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting N=36 --> 16
- Enrollment open, Tumor cell: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) (clinicaltrials.gov) - Mar 30, 2014
P=N/A, N=60, Recruiting, Sponsor: Duke University
N=36 --> 16 Not yet recruiting --> Recruiting
- dovitinib (TKI258) / Novartis, Oncoheroes
Enrollment open, Metastases: Dovitinib Plus Docetaxel in Gastric Cancer (clinicaltrials.gov) - Mar 26, 2014
P1/2, N=59, Recruiting, Sponsor: Asan Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| esomeprazole / Generic mfg.
Trial completion: Nexium Capsules Clinical Experience Investigation (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=3691, Completed, Sponsor: AstraZeneca
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| esomeprazole / Generic mfg.
Trial completion: Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation (clinicaltrials.gov) - Mar 25, 2014
P=N/A, N=369, Completed, Sponsor: AstraZeneca
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Herceptin (trastuzumab) / Roche
Enrollment closed: HerXO: Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive (clinicaltrials.gov) - Mar 23, 2014
P2, N=51, Active, not recruiting, Sponsor: Fundaci
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed: Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers (clinicaltrials.gov) - Mar 18, 2014
P=N/A, N=44, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment open: Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors (clinicaltrials.gov) - Mar 17, 2014
P1/2, N=133, Recruiting, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
New P2 trial, Metastases: Study of S-1 Plus LV for Advanced Gastric Cancer (clinicaltrials.gov) - Mar 16, 2014
P2, N=39, Completed, Sponsor: Sun Yat-sen University
- Biopsy: A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric Biopsy (clinicaltrials.gov) - Mar 13, 2014
P=N/A, N=20, Not yet recruiting, Sponsor: Yonsei University
- || Enrollment change: The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients (clinicaltrials.gov) - Mar 11, 2014
P=N/A, N=144, Completed, Sponsor: Seoul National University Hospital
Not yet recruiting --> Recruiting N=192 --> 144
- ||| Trial completion: The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients (clinicaltrials.gov) - Mar 11, 2014
P=N/A, N=144, Completed, Sponsor: Seoul National University Hospital
N=192 --> 144 Recruiting --> Completed
- ||||||| Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: AVAGAST: A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer (clinicaltrials.gov) - Mar 11, 2014
P3, N=774, Completed, Sponsor: Genentech
Recruiting --> Completed Active, not recruiting --> Completed
- ||| fexagratinib (ABSK091) / Abbisko
Enrollment change, Monotherapy, Metastases: SHINE: Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer (clinicaltrials.gov) - Mar 10, 2014
P2, N=960, Active, not recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Completed N=71 --> 960
- |||||||||| pantoprazole / Generic mfg., ilaprazole / Generic mfg.
New P3 trial: Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment (clinicaltrials.gov) - Mar 10, 2014
P3, N=320, Active, not recruiting, Sponsor: Il-Yang Pharm. Co., Ltd.
- | sunitinib / Generic mfg.
Trial completion, Combination therapy, Metastases: Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer (clinicaltrials.gov) - Mar 5, 2014
P1, N=27, Completed, Sponsor: Pfizer
N=71 --> 960 Active, not recruiting --> Completed
- |||| lapatinib / Generic mfg., capecitabine / Generic mfg.
Trial completion: Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib (clinicaltrials.gov) - Mar 5, 2014
P2, N=68, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| MM 111 / Elevation Oncology
Enrollment change: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach (clinicaltrials.gov) - Mar 3, 2014
P2, N=120, Recruiting, Sponsor: Merrimack Pharmaceuticals
Active, not recruiting --> Completed N=180 --> 120
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment change, Metastases: Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma (clinicaltrials.gov) - Mar 3, 2014
P2, N=6, Completed, Sponsor: Yonsei University
N=180 --> 120 N=62 --> 6
- New P2 trial, Metastases: Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. (clinicaltrials.gov) - Mar 3, 2014
P2, N=40, Recruiting, Sponsor: Arcispedale Santa Maria Nuova-IRCCS
- | New P1/2 trial: Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors (clinicaltrials.gov) - Mar 3, 2014
P1/2, N=133, Recruiting, Sponsor: University Hospital Inselspital, Berne
- docetaxel / Generic mfg., epirubicin / Generic mfg.
Enrollment open: A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin (clinicaltrials.gov) - Mar 3, 2014
P2, N=60, Recruiting, Sponsor: Yonsei University
N=62 --> 6 Not yet recruiting --> Recruiting
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial completion, Metastases: Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma (clinicaltrials.gov) - Mar 3, 2014
P2, N=6, Completed, Sponsor: Yonsei University
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open: Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=80, Recruiting, Sponsor: H
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| esomeprazole / Generic mfg.
Enrollment change: High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer (clinicaltrials.gov) - Feb 23, 2014
P3, N=600, Recruiting, Sponsor: AstraZeneca
Not yet recruiting --> Recruiting N=240 --> 600
- oxaliplatin / Generic mfg., capecitabine / Generic mfg.
New P2 trial, Surgery, Metastases: Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis (clinicaltrials.gov) - Feb 23, 2014
P2, N=48, Completed, Sponsor: Shanghai Zhongshan Hospital
- ||| NN1213 / Novo Nordisk
Trial completion: A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=148, Completed, Sponsor: The SmartPill Corporation
N=240 --> 600 Recruiting --> Completed
- |||| Trial completion: A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium (clinicaltrials.gov) - Feb 22, 2014
P4, N=520, Completed, Sponsor: Eisai Limited
Recruiting --> Completed Recruiting --> Completed
- | matuzumab (EMD 72000) / Takeda, EMD Serono
Trial completion, Combination therapy, Metastases: EMD 72000-024: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=26, Completed, Sponsor: Merck KGaA
Recruiting --> Completed No longer recruiting --> Completed
- | deoxyglucose / Generic mfg., docetaxel / Generic mfg.
Trial completion, Combination therapy, Metastases: Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=50, Completed, Sponsor: Threshold Pharmaceuticals
No longer recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Metastases: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Metastases: Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy (clinicaltrials.gov) - Feb 22, 2014
P2, N=28, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=47, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- || esomeprazole / Generic mfg.
Trial completion: Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome (clinicaltrials.gov) - Feb 22, 2014
P3, N=25, Completed, Sponsor: AstraZeneca
Active, not recruiting --> Completed No longer recruiting --> Completed
- | bortezomib / Generic mfg.
Trial completion, Metastases: Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial completion, Combination therapy, Metastases: Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=41, Completed, Sponsor: Taiho Pharma USA, Inc.
Active, not recruiting --> Completed No longer recruiting --> Completed
- | cisplatin / Generic mfg.
Trial completion, Metastases: Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | irofulven-1 (LP-100) / Lantern Pharma, Eisai
Trial completion, Metastases: Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Cancer Therapeutics Research Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | T900607 / Amgen
Trial completion: T900607 in Treating Patients With Gastroesophageal Junction Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: University Hospitals Seidman Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- tadalafil / Generic mfg.
Trial completion: Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying (clinicaltrials.gov) - Feb 22, 2014
P2, N=2, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Terminated --> Completed